News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sentigen Holding Corp. Announces The Sale Of Its Specialty Media Division To Serologicals Corporation's (SERO) CHEMICON International, Inc. (SERO)


10/19/2005 5:12:48 PM

PHILLIPSBURG, N.J.--(BUSINESS WIRE)--Feb. 22, 2005--Sentigen Holding Corp. (NasdaqSC: SGHL) today announced it has sold the Specialty Media Division of its wholly-owned subsidiary, Cell & Molecular Technologies, Inc. to Chemicon International, Inc., a wholly-owned subsidiary of Serologicals Corporation (Nasdaq: SERO). Under the terms of the agreement, Serologicals agreed to pay Sentigen Holding Corp. $6.5 million in cash, subject to certain post-closing adjustments and escrow, for the assets of the division. In addition to the purchase price Serologicals has retired the mortgage note with a balance of $243,310 on the division's facility at 580 Marshall Street, Phillipsburg, NJ 08865.

Read at BioSpace.com
Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES